Key points are not available for this paper at this time.
Abstract The MEG II experiment, located at the Paul Scherrer Institut (PSI) in Switzerland, is the successor to the MEG experiment, which completed data taking in 2013. MEG II started fully operational data taking in 2021, with the goal of improving the sensitivity of the ^+ e^+ μ+→e+γ decay down to 6 10^-14 ∼6×10-14 almost an order of magnitude better than the current limit. In this paper, we describe the operation and performance of the experiment and give a new estimate of its sensitivity versus data acquisition time.
Afanaciev et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: